Reckitt Benckiser looking into different option for its food business

Reckitt Benckiser looking into different option for its food business

Reckitt Benckiser looking into different option for its food business

According to latest reports, Reckitt Benckiser has said in a statement that it is set to start a strategic review of its food business, that could even be sold.

The company said it was taking into account “all options” for the unit, which comprises French’s mustard and sauce products.

Reports said that the firm is planning a sale to help fund its acquisition of US baby food maker, Mead Johnson, for $16.6 billion. Consumer goods giant products include Cillit Bang cleaning goods and painkiller Nurofen.

Meanwhile the company reportedly said French’s Food was a “truly fantastic business with great brands”, but was non-core.

“We have therefore decided to initiate a strategic review of food where we will explore all options.”

In the last 12 months period Reckitt’s stock have surged 9 % and was up 11p to £72.97 in morning trading.

Furthermore in the food division, which in 2016 had sales worth more than £400 million, could reach about £2.4 billion.

Reckitt also revealed to slash the salary of chief executive Rakesh Kapoor to £14.6 million from approximately £26 million in 2015.

Some shareholders had recently suggested that Mr Kapoor had pursued the Mead Johnson tie-up to make sure he hit well-paid bonus targets.

Moreover Mr. Kapoor said the deal was along the lines of company strategy and would help make  £200 million of cost savings after three years, even though it would not spawn a return for about five years.

Leave a reply

0 Comments

There are no comments on this post.

Risk Warning: Investing in digital currencies, stocks, shares and other securities, commodities, currencies and other derivative investment products (e.g. contracts for difference (“CFDs”) is speculative and carries a high level of risk. Each investment is unique and involves unique risks.

CFDs and other derivatives are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how an investment works and whether you can afford to take the high risk of losing your money.

Cryptocurrencies can fluctuate widely in prices and are, therefore, not appropriate for all investors. Trading cryptocurrencies is not supervised by any EU regulatory framework. Past performance does not guarantee future results. Any trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Your capital is at risk.

When trading in stocks your capital is at risk.

Past performance is not an indication of future results. Trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Prices may go down as well as up, prices can fluctuate widely, you may be exposed to currency exchange rate fluctuations and you may lose all of or more than the amount you invest. Investing is not suitable for everyone; ensure that you have fully understood the risks and legalities involved. If you are unsure, seek independent financial, legal, tax and/or accounting advice. This website does not provide investment, financial, legal, tax or accounting advice. Some links are affiliate links. For more information please read our full risk warning and disclaimer.